Klotho vs MOTS-c

Side-by-side comparison of Klotho, MOTS-c — mechanism, dosing, half-life, side effects, and research status.

← Pick different peptides
Attribute Klotho Klotho (α-Klotho) — Anti-Aging Protein/Peptide Longevity MOTS-c Mitochondrial Open Reading Frame of the 12S rRNA-c Longevity
Basics
Molecular type Anti-Aging Protein (Klotho Fragment)Mitochondria-Derived Peptide
Amino acids —16
Molecular weight —2,174.5 Da
Half-life Hours (circulating KL1 fragment)Short (hours)
Route(s) Subcutaneous (research), IV (research)Subcutaneous, IV (research)
Mechanism & Research
Primary mechanism Klotho acts as a co-receptor for fibroblast growth factor 23 (FGF23) in the kidney, regulating phosphate and vitamin D metabolism. However, its systemic anti-aging effects extend far beyond this co-receptor role through … MOTS-c activates AMPK (AMP-activated protein kinase), the master energy sensor of the cell. AMPK activation inhibits anabolic energy-consuming pathways, stimulates glucose uptake, drives fatty acid oxidation, and promote…
Research status Research Compound Research Compound
Evidence summary Klotho research has expanded dramatically since 2000. The most compelling recent finding was a 2023 Nature paper showing a single injection of Klotho fragment in aged mice produced sustained cognitive improvements — one … MOTS-c research has expanded rapidly since its discovery in 2015. Human plasma MOTS-c levels correlate inversely with age and with metabolic disease risk, supporting its physiological relevance in human ageing.
Protocol & Dosing
Typical dose Not established for human use; animal models used 10–100 mcg/kg5–10 mg per week
Frequency Unknown optimal frequency2–3x per week
Duration Experimental4–8 weeks
Timing Not establishedPre-exercise or morning
Safety
Common side effects
  • Unknown (insufficient human data)
  • Injection site redness
  • Mild fatigue (first week)
  • Increased appetite (possible)
Contraindications
  • Active malignancy (Klotho suppresses tumour-suppressive Wnt in some cancers — complex dual role)
  • Pregnancy (no data)
  • Severe hypophosphataemia (Klotho-FGF23 pathway regulation)
  • Pregnancy (no data)
  • Insulin-dependent diabetes (AMPK effects on glucose — monitor closely)
  • Active malignancy (AMPK has pro-survival roles in some cancers)
Anti-doping Not Prohibited Not Prohibited
Deeper reading
Related peptides Epithalon, Humanin, MOTS-c Humanin, SS-31, Epithalon
Full profile Read full Klotho profile → Read full MOTS-c profile →

Comparison data is compiled from each peptide’s individual profile. All values are drawn from peer-reviewed research and regulatory sources. For educational use only — not medical advice. Verify any protocol with a qualified healthcare provider.